Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Feb 12, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-10-006962.pdf 0001144204-10-006962.rtf 0001144204-10-006962.xls
Feb 12, 2010	424B1	Form of prospectus that discloses information previously omitted from the prospectus	View HTML 0001144204-10-006970.pdf 0001144204-10-006970.rtf 0001144204-10-006970.xls
Feb 11, 2010	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001144204-10-006579.pdf 0001144204-10-006579.rtf 0001144204-10-006579.xls
Feb 11, 2010	EFFECT	EFFECT	View HTML 9999999995-10-000483.pdf 9999999995-10-000483.rtf 9999999995-10-000483.xls
Feb 10, 2010	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001144204-10-006452.pdf 0001144204-10-006452.rtf 0001144204-10-006452.xls
Feb 10, 2010	CORRESP	CORRESP	View HTML 0001144204-10-006324.pdf 0001144204-10-006324.rtf 0001144204-10-006324.xls
Feb 8, 2010	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001144204-10-005819.pdf 0001144204-10-005819.rtf 0001144204-10-005819.xls
Feb 1, 2010	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001144204-10-004590.pdf 0001144204-10-004590.rtf 0001144204-10-004590.xls
Feb 1, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-10-004776.pdf 0001144204-10-004776.rtf 0001144204-10-004776.xls
Feb 1, 2010	CORRESP	CORRESP	View HTML 0001144204-10-004588.pdf 0001144204-10-004588.rtf 0001144204-10-004588.xls